Point72 Hong Kong LTD Vaxart, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $35,927 - $77,355	17,190 Added 468.9%	20,856 $45,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $5,497 - $10,750	2,036 Added 124.91%	3,666 $13,000
Q1 2022 May 16, 2022	BUY	$4.29 - $6.64 $6,992 - $10,823	1,630 New	1,630 $8,000
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $39,553 - $163,613	-7,013 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $6,769 - $15,433	1,934 Added 38.08%	7,013 $40,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $24,277 - $86,190	5,079 New	5,079 $34,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.